YU52999A - Kombinacija analgetika - Google Patents

Kombinacija analgetika

Info

Publication number
YU52999A
YU52999A YU52999A YU52999A YU52999A YU 52999 A YU52999 A YU 52999A YU 52999 A YU52999 A YU 52999A YU 52999 A YU52999 A YU 52999A YU 52999 A YU52999 A YU 52999A
Authority
YU
Yugoslavia
Prior art keywords
analgesic combination
analgesic
acting analgesic
combination
systematically
Prior art date
Application number
YU52999A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
Dieter Neuser
Monika Fierus
Wolfgang Wiehl
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of YU52999A publication Critical patent/YU52999A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
YU52999A 1997-04-15 1998-04-02 Kombinacija analgetika YU52999A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19715594A DE19715594A1 (de) 1997-04-15 1997-04-15 Analgetika-Kombination

Publications (1)

Publication Number Publication Date
YU52999A true YU52999A (sh) 2002-06-19

Family

ID=7826504

Family Applications (1)

Application Number Title Priority Date Filing Date
YU52999A YU52999A (sh) 1997-04-15 1998-04-02 Kombinacija analgetika

Country Status (23)

Country Link
US (1) US6929805B2 (OSRAM)
EP (1) EP0979087B1 (OSRAM)
JP (1) JP2002503221A (OSRAM)
KR (1) KR100532647B1 (OSRAM)
CN (1) CN1177589C (OSRAM)
AR (1) AR012417A1 (OSRAM)
AT (1) ATE253919T1 (OSRAM)
AU (1) AU742622B2 (OSRAM)
BR (1) BR9808875A (OSRAM)
CA (1) CA2285979C (OSRAM)
DE (2) DE19715594A1 (OSRAM)
DK (1) DK0979087T3 (OSRAM)
ES (1) ES2210754T3 (OSRAM)
HU (1) HU225601B1 (OSRAM)
NO (1) NO323022B1 (OSRAM)
NZ (1) NZ500262A (OSRAM)
PL (1) PL190863B1 (OSRAM)
PT (1) PT979087E (OSRAM)
RS (1) RS49620B (OSRAM)
RU (1) RU2218180C2 (OSRAM)
TR (1) TR199902396T2 (OSRAM)
WO (1) WO1998046235A1 (OSRAM)
YU (1) YU52999A (OSRAM)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6423697B1 (en) * 1999-01-14 2002-07-23 Mark Friedman Intraoral topical anti-inflammatory treatment for relief of migraine, tension-type headache, post-traumatic headache, facial pain, and cervical-muscle spasm
EP1231900A1 (en) * 1999-11-23 2002-08-21 The Robert Gordon University Bilayered buccal tablets comprising nicotine
AU3162001A (en) * 1999-12-21 2001-07-03 Id-Pharma Gmbh Medicament, a method for its production and the use thereof
KR20010069756A (ko) * 2001-05-08 2001-07-25 유형선 소염진통제인 아세메타신을 함유하며 장관내 특히대장에서의 약물 방출 속도가 조절되는 약물 전달 체계에대한 약제학적 경구용 조성물 및 그에 대한 제조방법
US20030035839A1 (en) * 2001-05-15 2003-02-20 Peirce Management, Llc Pharmaceutical composition for both intraoral and oral administration
US6863901B2 (en) 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
DE102004001093A1 (de) * 2004-01-05 2005-07-28 Liedtke, Rainer K., Dr. Zusammensetzung und Methode einer synergistischen topischen Therapie neuromuskulärer Schmerzen
DE102004040630A1 (de) * 2004-08-21 2006-03-09 Balaban, Romulus, Dr.med. Kombinationstherapie mit Procain
RU2283112C1 (ru) * 2005-10-04 2006-09-10 Открытое акционерное общество "Нижегородский химико-фармацевтический завод" Противовоспалительное лекарственное средство
EP2120945A1 (en) * 2007-02-28 2009-11-25 Collegium Pharmaceutical, Inc. Antihistamine combination
DE102008007212B3 (de) 2008-02-01 2009-10-15 BSH Bosch und Siemens Hausgeräte GmbH Gehäuse für den Antrieb eines elektrischen Geräts, insbesondere eines Haushaltsgeräts
US8690839B2 (en) 2008-08-01 2014-04-08 Tian Xia Devices for delivering a medicament and connector for same
US8231588B2 (en) * 2008-08-01 2012-07-31 Tian Xia Methods for ameliorating pain and devices for delivering a medicament
US8905980B2 (en) 2008-08-01 2014-12-09 Tian Xia Devices for delivering a medicament and methods for ameliorating pain
US20130049931A1 (en) * 2011-08-25 2013-02-28 Elwha LLC, a limited liability company of the State of Delaware Systems, devices, methods, and admixtures of transponders and food products for indication of food attributes
US10016580B2 (en) 2013-12-17 2018-07-10 Biovision Technologies, Llc Methods for treating sinus diseases
US9510743B2 (en) 2013-12-17 2016-12-06 Biovision Technologies, Llc Stabilized surgical device for performing a sphenopalatine ganglion block procedure
US9516995B2 (en) 2013-12-17 2016-12-13 Biovision Technologies, Llc Surgical device for performing a sphenopalatine ganglion block procedure
US9694163B2 (en) 2013-12-17 2017-07-04 Biovision Technologies, Llc Surgical device for performing a sphenopalatine ganglion block procedure
DE102015114799A1 (de) * 2015-09-04 2017-03-09 Knorr-Bremse Systeme für Nutzfahrzeuge GmbH Druckmittelaggregat, mit einem durch Spritzgießen hergestellten Gehäuse aus Kunststoff sowie Verfahren zu seiner Herstellung
WO2019064090A1 (en) * 2017-09-28 2019-04-04 Zenvision Pharma Llp NOVEL PHARMACEUTICAL COMPOSITION COMPRISING MEFENAMIC ACID AND OTHER ANALGESICS
WO2020005910A1 (en) 2018-06-28 2020-01-02 Sandler Scientific, Llc Sino-nasal rinse delivery device with agitation, flow-control and integrated medication management system
WO2025170507A1 (en) * 2024-02-07 2025-08-14 Oncozenge Ab A lozenge

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1026501A (en) 1961-10-13 1966-04-20 Upjohn Co Improvements in or relating to steroids and the manufacture thereof
US4446140A (en) * 1981-12-10 1984-05-01 Nelson Research & Development Company Method and composition for treating mouth pain
DE3328401A1 (de) 1983-08-05 1985-02-21 Merckle GmbH, 7902 Blaubeuren Injizierbare loesung zur behandlung von entzuendungen
US4851233A (en) 1986-10-06 1989-07-25 Warner-Lambert Company Sustained release formulations
US5064858A (en) * 1988-08-17 1991-11-12 Spectrum Pharmaceutical Corporation Protected complex of procaine for the treatment of symptoms from narcotics addiction, tinnitus and Alzheimer's disease
ATE114472T1 (de) 1989-09-21 1994-12-15 American Cyanamid Co System des typs ''einmal täglich'' zur gepulsten minocyclinabgabe.
IE66933B1 (en) * 1990-01-15 1996-02-07 Elan Corp Plc Controlled absorption naproxen formulation for once-daily administration
IT1242642B (it) 1990-04-17 1994-05-16 Alfa Wassermann Spa Formulazioni iniettabili contenenti naproxen sale sodico.
GB9121204D0 (en) 1991-10-04 1991-11-20 Euro Celtique Sa Medicament
ES2173096T3 (es) * 1992-08-05 2002-10-16 Faulding F H & Co Ltd Composicion farmaceutica peletizada.
US5609884A (en) * 1992-08-31 1997-03-11 G. D. Searle & Co. Controlled release naproxen sodium plus naproxen combination tablet
US5451409A (en) * 1993-11-22 1995-09-19 Rencher; William F. Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
US5702723A (en) * 1994-08-02 1997-12-30 Griffin; David Multi-stage delivery system for ingestible medications or nutrients
TW483763B (en) 1994-09-02 2002-04-21 Astra Ab Pharmaceutical composition comprising of ramipril and dihydropyridine compound
US5547948A (en) 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
JPH11502839A (ja) 1995-03-29 1999-03-09 ザ、プロクター、エンド、ギャンブル、カンパニー 鎮咳剤マイクロカプセル

Also Published As

Publication number Publication date
CA2285979C (en) 2009-11-24
KR100532647B1 (ko) 2005-12-02
HK1027505A1 (en) 2001-01-19
WO1998046235A1 (de) 1998-10-22
AU742622B2 (en) 2002-01-10
CN1252725A (zh) 2000-05-10
RS49620B (sr) 2007-08-03
DE59810166D1 (de) 2003-12-18
RU2218180C2 (ru) 2003-12-10
US20010002999A1 (en) 2001-06-07
EP0979087B1 (de) 2003-11-12
ATE253919T1 (de) 2003-11-15
PL336154A1 (en) 2000-06-05
PT979087E (pt) 2004-03-31
NO323022B1 (no) 2006-12-27
TR199902396T2 (xx) 2000-01-21
HU225601B1 (en) 2007-05-02
CN1177589C (zh) 2004-12-01
AU7428698A (en) 1998-11-11
ES2210754T3 (es) 2004-07-01
CA2285979A1 (en) 1998-10-22
HUP0003636A2 (hu) 2001-05-28
HUP0003636A3 (en) 2001-12-28
DK0979087T3 (da) 2004-03-08
NZ500262A (en) 2002-04-26
AR012417A1 (es) 2000-10-18
US6929805B2 (en) 2005-08-16
PL190863B1 (pl) 2006-02-28
KR20010006348A (ko) 2001-01-26
JP2002503221A (ja) 2002-01-29
DE19715594A1 (de) 1998-10-22
BR9808875A (pt) 2000-07-11
NO994663D0 (no) 1999-09-24
NO994663L (no) 1999-09-24
EP0979087A1 (de) 2000-02-16

Similar Documents

Publication Publication Date Title
EP1006998A4 (en) TOPICAL ACTIVE SUBSTANCE PREPARATIONS
IL117728A0 (en) Pharmaceutical compositions for transdermal administration
ZA965222B (en) Pharmaceutical orally applicable composition
IL110752A0 (en) Pharmaceutical composition for an hiv protease inhibitor
AUPN605795A0 (en) Analgesic pharmaceutical composition
IL138028A0 (en) Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical use
IL110588A0 (en) Bioadhesive emulsion preparations for enhanced drug delivery
SI0780369T1 (en) 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol derivatives as pharmaceutical agents
HUP9900964A3 (en) Protease inhibitors and pharmaceutical compositions containing these compounds
ZA987551B (en) Solid pharmaceutical dosage forms
GB9508015D0 (en) Topical pharmaceutical compositions
AU5387898A (en) Pharmaceutical agents
ZA9510427B (en) Pharmaceutical orally applicable composition
ZA9510428B (en) Pharmaceutical orally applicable composition
AU7428698A (en) Analgesic combination
GB9408842D0 (en) Pharmaceutical compositions for topical application
ZA944238B (en) New use of old drugs
FI954986L (fi) Uudet, suun kautta annettavat, syklosporiinia sisältävät farmaseuttiset valmisteet
GB9410898D0 (en) Pharmaceutical compositions having analgesic activity
IL110724A0 (en) Retroviral protease inhibitors, their preparation and pharmaceutical compositions containing them
WO1998038994A3 (de) Kombinationspräparat aus 2-methylthiazolidin-2,4-dicarbonsäure und paracetamol
GB9317752D0 (en) New pharmaceutical use
GB9323399D0 (en) Pharmaceutical formulations
EP0930070A4 (en) STABLE ASPIRIN-BASED Ointment
GB2275213B (en) Micronising mill